Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral amoxicillin and ciprofloxacin exposure in febrile hospitalized adults
NL-OMON49236Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ciprofloxacin and amoxicillin in bacterial disease (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoint: Area under the concentration-time curve. Started Aug 2019; status: active, not recruiting.
02
Drugs
ciprofloxacinamoxicillin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON49236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49236.